Author:
Huda Taha,Hussain Fawaz,Mani Hariharasudan,Gheith Shereen M,Skandan Savitri
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Rituximab. (2018). Accessed. May 7, 2024: https://www.ncbi.nlm.nih.gov/books/NBK548249/.
2. Rituximab-related reversible hepatocellular damage;Toprak SK;Turk J Haematol,2012
3. A case of rituximab-induced hepatitis;Del Prete CJ;Cancer Biother Radiopharm,2010
4. Acute hepatocellular damage secondary to rituximab-induced hepatitis;Upadhyay H;Am J Gastroenterol,2013
5. Rituximab-induced autoimmune hepatitis: a case study and literature review;Galiatsatos P;Can Liver J,2020